Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML

Hemasphere. 2019 Jun 4;3(3):e203. doi: 10.1097/HS9.0000000000000203. eCollection 2019 Jun.

Nicolas Duployez^{1

2}, Jean-Edouard Martin³, Sabine Khalife-Hachem³, Ryane Benkhelil¹, Véronique Saada⁴, Christophe Marzac^{4

5}, Nathalie Auger⁶, Alice Marceau-Renaut^{1

2}, Rémi Favier⁷, Paola Ballerini⁷, Olivier Caron⁸, André Baruchel⁹, Stéphane de Botton^{3

5}, Claude Preudhomme^{1

2}, Jean-Baptiste Micol^{3

5}, Hana Raslova⁵, Iléana Antony-Debré⁵

¹ Laboratory of Hematology, Université Lille Nord de France, Lille, France.
² INSERM UMR-S 1172, Lille, France.
³ Department of Hematology, Institut Gustave Roussy, Villejuif, France.
⁴ Laboratory of Hematology, Institut Gustave Roussy, Villejuif, France.
⁵ Inserm UMR1170, Institut Gustave Roussy, Université Paris Sud, Equipe Labellisée par la Ligue Nationale Contre le Cancer, Villejuif, France.
⁶ Biology and Pathology Department, Institut Gustave Roussy, Villejuif, France.
⁷ Assistance Publique-Hôpitaux de Paris, Laboratory of Hematology, Hôpital Trousseau, Paris, France.
⁸ Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
⁹ Assistance Publique-Hôpitaux de Paris, Department of Hematology, Hôpital Robert Debré, Paris, France.

No abstract available

Publication types